Logo image
Immune mechanisms driving alopecia areata: roles for effector T cells and pro-inflammatory pathways
Dissertation

Immune mechanisms driving alopecia areata: roles for effector T cells and pro-inflammatory pathways

Samuel J. Connell
University of Iowa
Doctor of Philosophy (PhD), University of Iowa
Spring 2026
DOI: 10.25820/etd.008541
pdf
Connell_Thesis_2026_final_v27.38 MB
Delayed release, Embargo ends: 06/29/2028

Abstract

Alopecia areata (AA) is a common autoimmune disease affecting approximately 2% of the global population. Clinically, AA presents as small defined patches of hair loss on the scalp, and in more severe cases can progress to complete loss of scalp or body hair. Disease onset most commonly occurs before the age of 40 and is associated with increased rates of psychological comorbidities including depression and anxiety, resulting in a diminished quality of life. The hair follicle is an immune privileged organ, and the loss of this privilege is thought to be a key driver of disease development. Lesional skin is characterized by dense lymphocytic infiltration of the hair follicle, particularly around the bulb region. In recent years, Janus kinase (JAK) inhibitors have emerged as an effective treatment strategy for AA and have recently received FDA approval. Despite favorable clinical outcomes, not all patients respond to treatment, highlighting the need for a more comprehensive understanding of the immune mechanisms that drive disease. The C3H/HeJ mouse strain develops spontaneous AA-like disease characterized by non-scarring hair loss and T cell infiltration of the follicle. Prior studies have identified NKG2D expressing CD8 T cells as key effector cells mediating destruction of the hair follicle through type II interferon dependent pathways. More recently, there has been a growing appreciation that additional immune cell populations and pro-inflammatory pathways may contribute to disease pathogenesis, however, specific mechanisms involved have not been clearly defined. The goal of my thesis work aimed to investigate the role of effector T cells and pro-inflammatory pathways in the development of AA. In this work, I demonstrate that CD4 T cells from the SDLNs of AA mice have the ability to transfer disease and exhibit an effector Th1 transcriptional and phenotypic profile. The pathogenic capacity of these cells was dependent on endogenous CD8 T cells, host IFN-g signaling, and CD4 T cell derived IFN-g production. Human AA skin showed a similar Th1 profile, highlighting the translational relevance of these findings. Beyond Th1 responses, I found elevated expression of chemokines and chemokine receptors in AA skin that promote CD8 T cell migration and retention in the skin. Additionally, AA skin exhibited increased IL-17 protein and transcript levels, and mice deficient in IL-17 receptor signaling showed delayed disease onset and reduced disease severity. Finally, disruption of NKG2D signaling reduced disease development but did not fully prevent AA, indicating it is not strictly required to sustain pathogenic CD8 T cell activity. Together, these findings define new mechanistic roles for effector T cells and pro-inflammatory pathways in AA, expanding our understanding of disease pathogenesis and identifying new potential targets for therapeutic intervention.
Autoimmunity Alopecia areata T cells

Details

Metrics

1 Record Views
Logo image